CellaVision AB (CEVI):企業の財務・戦略的SWOT分析

◆英語タイトル:CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14210
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

CellaVision AB (CEVI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis; software applications such as CellaVision remote review software and CellaVision remote review software Citrix ready; proficiency software; and accessories such as CellaVision light tower, HemaPrep and barcode label printer kit. Through its global partners, CellaVision distributes its products in Europe, the Middle East and Africa (EMEA), Asia Pacific and North America. CellaVision is headquartered in Lund, Sweden.

CellaVision AB Key Recent Developments

Feb 07,2019: CellaVision- year-end bulletin, Jan-Dec 2018
Oct 23,2018: CellaVision: Interim report January-September 2018
Oct 09,2018: CellaVision AB pesents the third quarter 2018 on October 23 at 11:00 CET
Jul 17,2018: CellaVision: Interim Report January-June 2018
May 03,2018: CellaVision: Interim report January-March 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
CellaVision AB – Key Facts
CellaVision AB – Key Employees
CellaVision AB – Key Employee Biographies
CellaVision AB – Major Products and Services
CellaVision AB – History
CellaVision AB – Company Statement
CellaVision AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
CellaVision AB – Business Description
Product Category: Instruments
Performance
Product Category: Other
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: The Americas
Performance
R&D Overview
CellaVision AB – Corporate Strategy
CellaVision AB – SWOT Analysis
SWOT Analysis – Overview
CellaVision AB – Strengths
CellaVision AB – Weaknesses
CellaVision AB – Opportunities
CellaVision AB – Threats
CellaVision AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
CellaVision AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
CellaVision AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 07, 2019: CellaVision- year-end bulletin, Jan-Dec 2018
Oct 23, 2018: CellaVision: Interim report January-September 2018
Oct 09, 2018: CellaVision AB pesents the third quarter 2018 on October 23 at 11:00 CET
Jul 17, 2018: CellaVision: Interim Report January-June 2018
May 03, 2018: CellaVision: Interim report January-March 2018
Apr 17, 2018: CellaVision: The Nomination Committee of CellaVision supplements its proposal with an additional Board member
Feb 09, 2018: CellaVision Year-end Bulletin 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
CellaVision AB, Key Facts
CellaVision AB, Key Employees
CellaVision AB, Key Employee Biographies
CellaVision AB, Major Products and Services
CellaVision AB, History
CellaVision AB, Other Locations
CellaVision AB, Subsidiaries
CellaVision AB, Key Competitors
CellaVision AB, Ratios based on current share price
CellaVision AB, Annual Ratios
CellaVision AB, Annual Ratios (Cont...1)
CellaVision AB, Annual Ratios (Cont...2)
CellaVision AB, Interim Ratios
CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
CellaVision AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
CellaVision AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
CellaVision AB, Performance Chart (2014 - 2018)
CellaVision AB, Ratio Charts
CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
CellaVision AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[CellaVision AB (CEVI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EMS SA:企業の戦略的SWOT分析
    EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Sutro Biopharma Inc (STRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline …
  • Radiation Monitoring Devices Inc:製品パイプライン分析
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipli …
  • Stamps.com Inc. (STMP):企業の財務・戦略的SWOT分析
    Stamps.com Inc. (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Accu-Break Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Prakash Industries Ltd (PRAKASH):企業の財務・戦略的SWOT分析
    Summary Prakash Industries Ltd (PIL) is a power and steel company. The company’s business activities include mining, steel and power, plastic and wind power. Its mining business division offers explores, acquires and develops iron ore and coal properties. PIL’s steel and power business division prov …
  • Pilot Energy Ltd (PGY):電力:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • American Electric Power Company, Inc. (AEP)-エネルギー分野:企業M&A・提携分析
    Summary American Electric Power Company, Inc. (AEP) is a holding company that carries out the generation, transmission and distribution of electricity through its subsidiaries. The company generates electricity through various sources of energy such as coal and lignite, natural gas, nuclear, and hyd …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), formerly Lijun International Pharmaceutical (Holding) Co Ltd is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bot …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cabela’S Inc
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • KSK Energy Ventures Ltd:発電所・企業SWOT分析
    KSK Energy Ventures Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • ScinoPharm Taiwan Ltd (1789):企業の財務・戦略的SWOT分析
    ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Linklaters Llp
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • Genting Berhad:戦略・SWOT・企業財務分析
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆